Document is current
Any future updates will be listed below
-
Authors
Nepveu-Traversy, Marie-Edith https://orcid.org/0000-0003-0936-6618
Hassanzadeh, Malihe
Bruneau-Cossette, Laurent
Besserer-Offroy, Élie https://orcid.org/0000-0002-7473-7043
Brouillette, Rebecca https://orcid.org/0000-0002-5466-9653
Morissette, Sandra
Traboulsi, Hassan
Kirby, Karyn
Murza, Alexandre
Longpré, Jean-Michel https://orcid.org/0000-0003-3985-2318
Breton, Billy
Gendron, Fernand-Pierre https://orcid.org/0000-0002-4731-4352
Gaudreau, Simon
Boudreault, Pierre-Luc https://orcid.org/0000-0002-2032-7970
Sarret, Philippe https://orcid.org/0000-0002-7627-701X
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-148413)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 27 October 2025
First Online: 12 December 2025
Competing interests
: M.E.N.T., P.L.B., H.T., S.G., E.M., and P.S. are patent holders related to this work. S.G. is also a scientific cofounder of Immune Biosolutions. B.B. serves as the Chief Scientific Officer (C.S.O.) of Domain Therapeutics. The remaining authors declare no competing interests.
